Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting

2 Mar 2017

Abstract excerpt

Colorectal cancer (CRC) is the third most common cancer worldwide. If detected at an early stage, prognosis is good. Despite increasing evidence for the benefits of implemented screening programs, such as screening colonoscopy, compliance is rather low. Hence there is demand for non-invasive tests for the early detection of CRC with high acceptance in population-wide screening. The objective of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Epigenetics and DNA Methylation
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28270869
DOI: 10.1186/s13148-017-0322-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening settingPMID 28270869Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal CancerSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control studySemantic proximity Read ↗

Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal CancerSemantic proximity Read ↗

Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early DetectionSemantic proximity Read ↗

Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision MedicineSemantic proximity Read ↗

Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assaySemantic proximity Read ↗

A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibilitySemantic proximity Read ↗

Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of DiseaseSemantic proximity Read ↗

DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal CancerSemantic proximity Read ↗

Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.